6996 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Antengene Corp. Ltd. operates as a clinical-stage Asia-Pacific biopharmaceutical company, which engages in oncology medicines, R&D capabilities, and differentiated strategic approach to developing novel oncology therapies. It operates in the segments of the pharmaceutical, biotechnology and other related markets that address oncology diseases. The company was founded by Jian Ming Mei on August 28, 2018, and is headquartered in Shanghai, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
No dividends
6996 has never paid dividends and has no current plans to do so.
Financial health
Financial position and solvency of the company